BAT Says Potential COVID-19 Vaccine Using Tobacco Leaves Ready For Human Trials
World’s No.2 cigarette company British American Tobacco said it was ready to test its potential COVID-19 vaccine using proteins from tobacco leaves on humans, after it generated a positive immune response in pre-clinical trials.
The maker of Lucky Strike cigarette said once it gets approval from the US Food and Drug administration (FDA) for the vaccine, it would progress to Phase 1 trials or testing on humans.
The company raised eyebrows in April when it said it was developing a COVID-19 vaccine from tobacco leaves and could produce 1 million to 3 million doses per week if it got the support of government agencies and the right manufacturers.
ESM
Related news
France kicks off bird flu vaccination despite trade backlash risk
France began vaccinating ducks against bird flu on Monday to…
Read more >The durable and transparent packaging is the winner – results on the soup paste dry pasta Product sample
We asked the reviewers during the soup paste dry pasta…
Read more >Magazine: László Krisán: “Everyone has their share of responsibility in crisis management”
Our magazine asked László Krisán, the CEO of KAVOSZ Zrt.…
Read more >Related news
Pick Szeged Zrt.’s profit decreased, but its sales revenue increased last year
Pick Szeged Zrt.’s after-tax profit in 2024 was 6.7 billion…
Read more >Nestlé’s solar park in Szerencs was handed over
Nestlé inaugurates a new solar park at its Central European…
Read more >140 million bottles returned at ALDI
In ALDI Hungary stores, customers have returned a record amount…
Read more >